Heart Health on Achievement 

In collaboration with the American College of Cardiology (ACC), Evidation has launched a nationwide initiative focusing  on the lived experience of individuals with heart failure beyond the clinic walls, to understand their particular needs and sources of value which could improve engagement and outcomes.

Over 1000 people with heart failure and other chronic conditions (as of April 2021) from across 48 states and the District of Columbia have agreed to participate, recruited in less than 1 month from Evidation’s Achievement app.

Screen Shot 2021-04-19 at 10.06.46 AM

Person-Generated Health Data

 PGHD allows us to understand the heart failure lived experience outside the clinic for a wider population, and allows individuals to tell their own story.


Through PGHD, we can identify individuals who could benefit from engagement and nudge them towards evidence supported actions. 

Digital Tools 

We can identify individuals with heart failure that are not being managed well and engage them via digital tools, ultimately improving health outcomes.

Recent Insights

As of May 25, 2021

Geographic Reach

474 heart failure participants from across the United States joined the study, representing 48/50 states and a 80:20 mix of urban and rural.

  • Why it matters: Inequalities in access and treatment play a large role in Heart Failure outcomes, it is critical to meet patients where they are, both in their journey and also physically.
Figures_Figure 1


Participants shared up to 5 years of retrospective wearable data, in many cases covering their entire Heart Failure journey: pre-diagnosis, diagnosis, hospitalizations and medication changes, as well as current symptoms and trajectories.

  • Why it matters: Participants are enabling us to understand their entire journey and study the impact of Heart Failure on their behavior and outcomes over long periods of time. This helps us identify individual personas and trajectories, and derive personalized insights which help that individual engage with their own health.
Figures_v5_Figure 2

Device Usage

We observe high levels of device usage across demographic, socio-economic and ethnic groups.

  • Why it matters: Low-burden and highly popular mobile technologies enable all patients to have their voice heard. 
Figures_v4_Figure 3-4


76% of participants reported being aware of their symptoms prior to diagnosis, and 25% for months or years before their diagnosis. 61%  participants have a connected wearable device, of which 9% participants shared dense (no more than 4 consecutive missing days, no more than 15 days missing in a month) wearable data covering their entire journey all the way to diagnosis.

Figures_v3_Figure 5


89% of participants had been hospitalized at least once, and 24% participants shared dense (no more than 4 consecutive missing days, no more than 15 days missing in a month) wearable data covering their most recent hospitalization.

Figures_v3_Figure 6


11-13% report not regularly taking any medications for their HF, and of those that are, 53% participants reported feeling no change or worsening symptoms since last medication change.

Figures_v5_Figure 7